CG Inflammatory Bowel Disease Event

Please join us virtually for this one-day event featuring private companies and professors across the Healthcare sector. Over the last 10 years the IBD space has witnessed multiple new drug approvals along with new mechanisms of action. Our discussion will focus on how much these new drugs have changed the treatment of IBD and what is on the GI Doc’s wish list for new treatments.

For more information please contact Ashley valliere at avalliere@cgf.com